UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

O26 Les patients diabétiques de type 2 (DT2) avec un bon contrôle glycémique sous insuline ont moins d’événements cardiovasculaires et de mortalité: résultats de l’étude CREDIT

Diabetes & metabolism, 2015-03, Vol.41, p.A8-A8

2015

Volltextzugriff (PDF)

Insulin glargine provides greater improvements in glycaemic control vs. intensifying lifestyle management for people with type 2 diabetes treated with OADs and 7-8% A1c levels. The TULIP study

Diabetes, obesity & metabolism, 2009-04, Vol.11 (4), p.379-386

2009

Volltextzugriff (PDF)

Monitoring individual response to hormone replacement therapy with bone markers

Bone (New York, N.Y.), 2000-06, Vol.26 (6), p.553-560

2000

Volltextzugriff (PDF)

Matrix delivery transdermal 17β-estradiol for the prevention of bone loss in postmenopausal women

Osteoporosis international, 1999-04, Vol.9 (4), p.358-366

1999

Volltextzugriff (PDF)

A dose-ranging trial of a matrix transdermal 17β-estradiol for the prevention of bone loss in early postmenopausal women

Bone (New York, N.Y.), 1999-05, Vol.24 (5), p.517-523

1999

Volltextzugriff (PDF)

Efficacy of continuous sequential transdermal estradiol and norethindrone acetate in relieving vasomotor symptoms associated with menopause

American journal of obstetrics and gynecology, 2000-01, Vol.182 (1), p.7-12

2000

Volltextzugriff (PDF)

Three-year follow-up of the use of transdermal 17β-estradiol matrix patches for the prevention of bone loss in early postmenopausal women

American journal of obstetrics and gynecology, 2001-01, Vol.184 (2), p.32-40

2001

Volltextzugriff (PDF)

Efficacy and tolerability of Menorest ® 50 compared with estraderm ® TTS 50 in the treatment of postmenopausal symptoms. A randomized, multicenter, parallel group study

Maturitas, 1995-11, Vol.22 (3), p.207-218

1995

Volltextzugriff (PDF)

A randomized comparison of continuous combined transdermal delivery of estradiol-norethindrone acetate and estradiol alone for menopause

Obstetrics and gynecology (New York. 1953), 1999-10, Vol.94 (4), p.498-503

Archer, D

1999

Volltextzugriff (PDF)

Efficacy and tolerance of Menorest ® compared to Premarin ® in the treatment of postmenopausal women. A randomised, multicentre, double-blind, double-dummy study

Maturitas, 1995-09, Vol.22 (2), p.105-114

1995

Volltextzugriff (PDF)

Bioavailability Study of Menorest®, a New Estrogen Transdermal Delivery System, Compared with a Transdermal Reservoir System

Clinical drug investigation, 1995-09, Vol.10 (3), p.172-178

1995

Volltextzugriff (PDF)

Effects of transdermal hrt on vasomotor symptoms using either a sequential regimen or a continuous combined regimen

International journal of gynecology and obstetrics, 2000, Vol.70 (S3), p.C55-C56

2000

Volltextzugriff (PDF)

P3.13.04 Effect of transdermal estradiol/norethisterone HRT vs. estradiol on quality of life in postmenopausal women

International journal of gynecology and obstetrics, 2000, Vol.70 (S3), p.C119-C119

2000

Volltextzugriff (PDF)

Studies on the safety of treatment with transdermal patches containing estradiol and norethisterone (Estalis®)

International journal of gynecology and obstetrics, 2000, Vol.70 (S4), p.D138-D138

2000

Volltextzugriff (PDF)

Efficacy and Safety of Menorest (50 Mikrog/Day) Compared to Premarin 0.625 Mg in the Treatment of Menopausal Symptoms and the Prevention of Bone Loss, in Menopausal Women: A Single-center, Comparative, Randomized, Double-blind, Double-dummy Study

Scandinavian journal of rheumatology, 1996, Vol.25 (S103), p.89-90

1996

Volltextzugriff (PDF)

Clinical Evaluation of a New Triphasic Oral Contraceptive: Norgestimate and Ethinyl Estradiol

Acta obstetricia et gynecologica Scandinavica, 1992-01, Vol.71 (S156), p.27-32

1992

Volltextzugriff (PDF)

A Double-Blind, Double-Dummy, Comparative Study of Menorest 50® versus Premarin® 0.625mg in the Treatment of Menopausal Symptoms and the Prevention of Bone Loss in Patients with Menopausal Symptoms

Clinical drug investigation, 1996-04, Vol.11 (4), p.205-213

1996

Volltextzugriff (PDF)

A Comparison Study of Lipid and Androgen Metabolism with Triphasic Oral Contraceptive Formulations Containing Norgestimate or Levonorgestrel

Acta obstetricia et gynecologica Scandinavica, 1992-01, Vol.71 (S156), p.33-38

1992

Volltextzugriff (PDF)

PDB79 DURATION OF FIRST INSULIN THERAPY IN PREVIOUSLY UNCONTROLLED TYPE 2 DIABETES: COMPARISON OF INSULINS GLARGINE, DETEMIR AND NPH AND ASSOCIATION WITH GLYCEMIC CONTROL

Value in health, 2010, Vol.13 (7), p.A298-A298

2010

Volltextzugriff (PDF)

Effects on blood lipid and androgen levels of two triphasic oral contraceptives

International journal of fertility and menopausal studies, 1993, Vol.38 Suppl 3, p.114

1993

Volltextzugriff (PDF)

PDB56 THE IMPACT OF STARTING INSULIN GLARGINE VERSUS INSULIN DETEMIR ON QUALITY OF LIFE (QOL) AND TREATMENT SATISFACTION (TS) IN PATIENTS WITH TYPE 2 DIABETES INADEQUATELY CONTROLLED ON ORAL GLUCOSE-LOWERING DRUGS (OGLDS)

Value in health, 2009, Vol.12 (7), p.A412-A412

2009

Volltextzugriff (PDF)

PDB14 2-YEAR GLYCEMIC CONTROL FOLLOWING INITIATION OF INSULIN GLARGINE VERSUS NPH INSULIN IN INDIVIDUALS WITHTYPE 2 DIABETES (T2DM)

Value in health, 2007, Vol.10 (6), p.A257-A258

2007

Volltextzugriff (PDF)

Efficacy of Pancrease: Crossover Comparative Study versus Eurobiol in Cystic Fibrosis

Journal of pediatric gastroenterology and nutrition, 1988-11, Vol.7, p.S46-S48

1988

Volltextzugriff (PDF)

A dose-ranging trial of a matrix transdermal 17beta-estradiol for the prevention of bone loss in early postmenopausal women. International Study Group

Bone (New York, N.Y.), 1999-05, Vol.24 (5), p.517-523

1999

Volltextzugriff (PDF)

A randomized comparison of continuous combined transdermal delivery of estradiol-norethindrone acetate and estradiol alone for menopause. CombiPatch Study Group

Obstetrics and gynecology (New York. 1953), 1999-10, Vol.94 (4), p.498

1999

Volltextzugriff (PDF)

1 – 25 von 125

Suche als RSS-Feed

Aktive Filter

ThemaMale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(105)
Mit Volltextzugriff
(101)

Publikationsform

Sprache

Englisch
(113)
Französisch
(12)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

O26 Les patients diabétiques de type 2 (DT2) avec un bon contrôle glycémique sous insuline ont moins d’événements cardiovasculaires et de mortalité: résultats de l’étude CREDIT

Insulin glargine provides greater improvements in glycaemic control vs. intensifying lifestyle management for people with type 2 diabetes treated with OADs and 7-8% A1c levels. The TULIP study

Monitoring individual response to hormone replacement therapy with bone markers

Matrix delivery transdermal 17β-estradiol for the prevention of bone loss in postmenopausal women

A dose-ranging trial of a matrix transdermal 17β-estradiol for the prevention of bone loss in early postmenopausal women

Efficacy of continuous sequential transdermal estradiol and norethindrone acetate in relieving vasomotor symptoms associated with menopause

Three-year follow-up of the use of transdermal 17β-estradiol matrix patches for the prevention of bone loss in early postmenopausal women

Efficacy and tolerability of Menorest ® 50 compared with estraderm ® TTS 50 in the treatment of postmenopausal symptoms. A randomized, multicenter, parallel group study

A randomized comparison of continuous combined transdermal delivery of estradiol-norethindrone acetate and estradiol alone for menopause

Efficacy and tolerance of Menorest ® compared to Premarin ® in the treatment of postmenopausal women. A randomised, multicentre, double-blind, double-dummy study

Bioavailability Study of Menorest®, a New Estrogen Transdermal Delivery System, Compared with a Transdermal Reservoir System

Effects of transdermal hrt on vasomotor symptoms using either a sequential regimen or a continuous combined regimen

P3.13.04 Effect of transdermal estradiol/norethisterone HRT vs. estradiol on quality of life in postmenopausal women

Studies on the safety of treatment with transdermal patches containing estradiol and norethisterone (Estalis®)

Efficacy and Safety of Menorest (50 Mikrog/Day) Compared to Premarin 0.625 Mg in the Treatment of Menopausal Symptoms and the Prevention of Bone Loss, in Menopausal Women: A Single-center, Comparative, Randomized, Double-blind, Double-dummy Study

Clinical Evaluation of a New Triphasic Oral Contraceptive: Norgestimate and Ethinyl Estradiol

A Double-Blind, Double-Dummy, Comparative Study of Menorest 50® versus Premarin® 0.625mg in the Treatment of Menopausal Symptoms and the Prevention of Bone Loss in Patients with Menopausal Symptoms

A Comparison Study of Lipid and Androgen Metabolism with Triphasic Oral Contraceptive Formulations Containing Norgestimate or Levonorgestrel

PDB79 DURATION OF FIRST INSULIN THERAPY IN PREVIOUSLY UNCONTROLLED TYPE 2 DIABETES: COMPARISON OF INSULINS GLARGINE, DETEMIR AND NPH AND ASSOCIATION WITH GLYCEMIC CONTROL

Effects on blood lipid and androgen levels of two triphasic oral contraceptives

PDB56 THE IMPACT OF STARTING INSULIN GLARGINE VERSUS INSULIN DETEMIR ON QUALITY OF LIFE (QOL) AND TREATMENT SATISFACTION (TS) IN PATIENTS WITH TYPE 2 DIABETES INADEQUATELY CONTROLLED ON ORAL GLUCOSE-LOWERING DRUGS (OGLDS)

PDB14 2-YEAR GLYCEMIC CONTROL FOLLOWING INITIATION OF INSULIN GLARGINE VERSUS NPH INSULIN IN INDIVIDUALS WITHTYPE 2 DIABETES (T2DM)

Efficacy of Pancrease: Crossover Comparative Study versus Eurobiol in Cystic Fibrosis

A dose-ranging trial of a matrix transdermal 17beta-estradiol for the prevention of bone loss in early postmenopausal women. International Study Group

A randomized comparison of continuous combined transdermal delivery of estradiol-norethindrone acetate and estradiol alone for menopause. CombiPatch Study Group

Aktive Filter

Suchergebnisse filtern